Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06812416 · ClinicalTrials.gov registry record · NA
Effectiveness of Qualia NAD+ Supplementation on NAD Levels
A NA study of Intracellular NAD+ Levels, sponsored by Qualia Life Sciences.
- Completed
- Registry status
- NA
- Development phase
- 92
- Enrollment target
- 1
- Study location
NCT06812416 is a NA study of Intracellular NAD+ Levels that has completed, run by Qualia Life Sciences. The registered enrollment target is 92 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06812416, a NA study of Intracellular NAD+ Levels, has completed, sponsored by Qualia Life Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 92 participants
- Enrollment target
- 1
- Study location
Study Summary
The current study is designed as a randomized double-blind placebo-controlled parallel trial. It aims to investigate the efficacy of Qualia NAD+ on intracellular NAD levels in blood samples (primary outcomes) and health-related quality of life (secondary outcomes) in an adult population experiencing moderate to severe joint pain between ages of 40 and 65 years.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Qualia NAD+
- DIETARY_SUPPLEMENT Rice Flour Placebo
Study Locations (1)
California
- Remote Study - Carlsbad
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2023-10-24 |
| Est. Completion | 2024-03-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06812416
The ClinicalTrials.gov registry entry for NCT06812416 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Qualia Life Sciences, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Intracellular NAD+ Levels appearing as the primary indexed condition, and to 2 interventions - of which Qualia NAD+ is the first listed.
NCT06812416 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06812416 about?
NCT06812416 is a clinical study titled "Effectiveness of Qualia NAD+ Supplementation on NAD Levels". The current study is designed as a randomized double-blind placebo-controlled parallel trial. It aims to investigate the efficacy of Qualia NAD+ on intracellular NAD levels in blood samples (primary outcomes) and health-related quality of life (secondary outcomes) in an adult population experiencing...
What is the current status of trial NCT06812416?
This trial is currently completed. It is a NA study. The enrollment target is 92 participants. The study started on 2023-10-24. Estimated completion is 2024-03-11.
What conditions does trial NCT06812416 study?
This clinical trial studies the following conditions: Intracellular NAD+ Levels.
What interventions are being tested in trial NCT06812416?
The interventions under investigation include: Qualia NAD+ (DIETARY_SUPPLEMENT), Rice Flour Placebo (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06812416?
This trial is sponsored by Qualia Life Sciences, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06812416 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.